WO2001047862A1 - Optically active materials - Google Patents

Optically active materials Download PDF

Info

Publication number
WO2001047862A1
WO2001047862A1 PCT/CH2000/000673 CH0000673W WO0147862A1 WO 2001047862 A1 WO2001047862 A1 WO 2001047862A1 CH 0000673 W CH0000673 W CH 0000673W WO 0147862 A1 WO0147862 A1 WO 0147862A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
group
optionally
chiral
coo
Prior art date
Application number
PCT/CH2000/000673
Other languages
French (fr)
Inventor
Zoubair Mohammed Cherkaoui
Klaus Schmitt
Original Assignee
Rolic Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolic Ag filed Critical Rolic Ag
Priority to US10/168,137 priority Critical patent/US6905739B2/en
Priority to JP2001549336A priority patent/JP2003519113A/en
Priority to EP00982805A priority patent/EP1252131A1/en
Priority to AU19795/01A priority patent/AU1979501A/en
Priority to KR1020027008072A priority patent/KR20020062767A/en
Publication of WO2001047862A1 publication Critical patent/WO2001047862A1/en
Priority to HK02109386.1A priority patent/HK1047740A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/58Dopants or charge transfer agents
    • C09K19/586Optically active dopants; chiral dopants
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • C09K19/2014Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups containing additionally a linking group other than -COO- or -OCO-, e.g. -CH2-CH2-, -CH=CH-, -C=C-; containing at least one additional carbon atom in the chain containing -COO- or -OCO- groups, e.g. -(CH2)m-COO-(CH2)n-
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • C09K19/2021Compounds containing at least one asymmetric carbon atom
    • C09K19/2028Compounds containing at least one asymmetric carbon atom containing additionally a linking group other than -COO- or -OCO-, e.g. -CH2-CH2-, -CH=CH-, -C=C-; containing at least one additional carbon atom in the chain containing -COO- or -OCO- groups, e.g. -COO-CH*-CH3
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition

Abstract

A compound is of formula (I), in which: A?1 to A4, E1 and E2¿ each independently represent hydrogen or an optionally-substituted hydrocarbon group; B?1 and B2¿ each independently represent a single bond, an oxygen atom or an optionally-substituted hydrocarbon group; MG?1 and MG2¿ each independently represent an optionally-substituted ring system; CG is a divalent or polyvalent chiral group. The optically active compound may be used as a doping agent for liquid crystals for a wide range of applications including solid state cholesteric filters for projection displays, circular polarisers, optical filters, etc.

Description

Optically active materials
This invention relates to optically active materials and their use as doping agents for liquid crystals for a wide range of applications including solid state cholesteric filters for projection displays, circular polarisers, optical filters, etc.
The addition of an optically-active compound to a non-optically-active liquid crystalline phase is one of procedures used for the conversion of non-optically-active into optically-active mesophases. The nematic phase, for example, is converted to the cholesteric one when being doped with a small amount of an optically-active substance. This conversion manifests itself by the occurrence of an intermolecular helix which is characterised by the so-called helical twisting power (HTP) given in Equation 1 :
Figure imgf000002_0001
HTP (μm_1) helical twisting power for small concentrations p (μm) pitch of induced helix, + for (P)- κ ιx, - for (MJ- olϊx x mole fraction of the dopant sum over all optically-active conformers of the dopant x, mole fraction of conformer i
Said HTP is in fact a measure for the efficiency of a given dopant and is determined by the Cano method with solutions of the dopant in the host mesophase. Since the optically-active guest and the non-optically-active host compounds are not necessarily compatible at the molecular scale, their binary solution is frequently characterised by undesirable changes of the thermotropic sequence of the initial host liquid crystalline material, like for example a depression of the clearing point. Those changes could in turn have negative effects on the phase properties of the host, such as a decrease of the birefringence etc. Therefore, an optically-active dopant is sought so that with very small concentrations of this latter, large values of HTP could be induced. As such efficient optically-active dopants there are the binaphthol derivatives described in GB-A-2 298 202. However optically-active binaphthol derivatives may undergo partial racemisation when being heated. Besides, their preparation is expensive because it includes asymmetric resolution of binaphthol racemate as a crucial reaction step.
Other classes of optically active dopants which are of easier chemical access than binaphthol derivatives are those described in US-5, 780,629, which are consisting of compounds having at least one divalent or polyvalent chiral group and at least one mesogenic group. Based on this molecular architecture, in which the chiral group is present at peripheral positioti of the mesogenic cores, we have prepared some chiral dimesogenic derivatives. Nevertheless, their use as doping agents for liquid crystals has only provided mixtures with a relatively small HTP. However, we have now discovered that a further class of compounds, including within its scope compounds that exhibit a chiral group at lateral positions of at least two rod-like shaped organic residues, is efficient for producing a large HTP. Besides, their synthesis is trivial and inexpensive since they are obtained in few reaction steps starting from commercially available optically active residues.
Thus, the invention provides chiral "sandwich" derivatives of formula I:
Figure imgf000003_0001
in which A1 to A4 each independently represent hydrogen, an optionally-substituted methyl group, or an optionally-substituted hydrocarbon group of 2 to
80 C-atoms, in which one or more C-atoms may be replaced by a heteroatom, in such a way that oxygen atoms are not linked to one another,
E* and E2 each independently represent hydrogen, an optionally-substituted methyl group, or an optionally-substituted hydrocarbon group of 2 to
80 C-atoms, in which one or more C-atoms may be replaced by a heteroatom, in such a way that oxygen atoms are not linked to one another,
B1 and B2 each independently represent a single bond, an oxygen atom or an optionally-substituted hydrocarbon group of 1 to 80 C-atoms, in which one or more C-atoms may be replaced by a heteroatom, in such a way that oxygen atoms are not linked to one another,
MG1 and MG2 each independently represent an optionally-substituted aromatic or non-aromatic carbocyclic or heterocyclic ring system, with 1 to 80 C-atoms,
CG is a divalent or polyvalent chiral group derived, in particular, from sugars, from optically active biaryls such as optionally substituted binaphthyl or optionally substituted biphenyl, or from bifunctional or polyfunctional compounds such as optically active alcohols, glycols or amino acids, and
nl and n2 are each independently 1 or 2, where "nl = 2" (or "n2 = 2") indicates the presence of two separate linkages via the groups B1 (or the groups B2) between the groups MG1 and CG (or CG and MG2),
J - and in which further the substructures A^MG'-A2 and A3-MG2-A4 each have a longitudinal axis and are linked lateral to the said longitudinal axis to B1 and B2, respectively.
One possibility to form a longitudinal axis in the substructures N^-MG^-A2 and A3-MG2-A4 are compounds where two or more rings or a fused ring system are present in MG1 or MG2. Another possibility are compounds where at least one of A1 or A2 and A3 or A4 is different from hydrogen.
The compounds of the present invention are efficient for producing a large HTP.
Their synthesis is trivial and inexpensive since they are obtained in few reaction steps starting from commercially available optically active residues.
They are compatible with liquid-crystalline compounds or liquid-crystalline mixtures (no significant change of the clearing temperatures when used as dopants in a liquid- crystalline matrix).
They induce a large supercooling effect at the liquid-crystalline state when used as dopants in liquid-crystalline matrix hence avoiding crystallisation problems during the manufacture of cholesteric films.
They may be used as doping agents for liquid crystals for a wide range of applications including solid state cholesteric filters for projection displays, circular polarisers, optical filters, etc.
Preferred compounds of the present invention are those belonging to formula (I), in which:
nl = n2 = l . Preferably at least one of A1 to A4 , E1 and E2 includes a polymerisable group, and each independently may be selected from formula (II):
Figure imgf000006_0001
wherein:
P is hydrogen or a polymerisable group selected from groups comprising CH2=CW-, CH2=W-O-, CH2=CW-COO-, CH2=C(Ph)-COO-,
CH2=CH-COO-Ph-, CH2=CW-CO-NH-, CH2=C(Ph)-CONH-, CH2=C(COOR')-CH2-COO-, CH2=CH-O-, CH2=CH-OOC-, (Ph)-CH=CH-,
CH3-C=N-(CH2)m3-, HO-, HS-, HO-(CH2)m3-, HS-(CH2)m3-, HO(CH2)m COO-, HS(CH2)m3COO-, HWN-, HOC(O)-, CH2=CH-Ph-(O)m4.
Figure imgf000006_0002
wherein: W represents H, F, CI, Br or I or a C i-5 alkyl group; m3 is an integer having a value of from 1 to 9; m4 is an integer having a value of 0 or 1, R' represents a C ι-5 alkyl group; and R" represents a C1-5 alkyl group, methoxy, cyano, F, CI, Br or I;
Sp1 represents an optionally-substituted Ci-2o alkylene group, in which one or more C-atoms may be replaced by a heteroatom;
k1 is an integer having a value of from 0 to 4;
X1 represents -O-, -S-, -NH-, N(CH3)-, -CH(OH)-, -CO-, -CH2(CO)-, -SO-, -CH2(SO)-, -SO2-, -CH2(SO2)-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -SOO-, -OSO-, -SOS-, -CH2-CH2-, -OCH2-, -CH2O-, -CH=CH-, or -C≡C-; and t1 is an integer having a value of 0 or 1
In relation to the residue of formula (II), the term Ph is to be understood as denoting phenylene and (Ph) as denoting phenyl
The Ci-20 alkylene group Sp1 may comprise branched or straight chain alkylene groups and may be unsubstituted, mono- or polysubstituted by F, CI, Br, I or CN Alternatively or in addition one or more of CH2 groups present in the hydrocarbon chain may be replaced, independently, by one or more groups selected from -O-, -S-, -NH-, N(CH3)-, -CH(OH)-, -CO-, -CH2(CO)-, -SO-, -CH2(SO)-, -SO2-, -CH2(SO2)-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -SOO-, -OSO-, -SOS-, -C≡C-, -(CF2)-r , -(CD2)S- or C(W1)=C(W2)-, with the proviso that no two oxygen atoms are directly linked to each other W1 and W2 each represent, independently, H, H-(CH2)qι- or CI The integers r, s and ql each independently represent a number of between 1 and 15
More preferably, A1 to A4 and E1 to E2 each independently represent a group of formula (III)
P -Sp5-X4- (III) wherein
P2 represents hydrogen, CH2=C W5- or CH2=C W5-(CO) O-,
Figure imgf000007_0001
wherein W5 represents H, CH3, F, CI, Br or I, and v2 is O or l,
R' represents a C1-5 alkyl group, and R" represents a C1-5 alkyl group, methoxy, cyano, F, CI, Br or I, Sp5 represents a Cι_ o straight-chain alkylene group, especially ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, or dodecylene, and
X4 represents -O-, -CO-, -COO-, -OCO-, -C≡C-, or a single bond, especially -O-, -COO-, -OCO- or single bond
One or more of A1 to A4 and E1 to E2 may also represent a Ci-C o-alk>l, Cι-C2o-alkoxy, Cι-C-alkoxycarbonyl, Cι-C o-alkylcarbonyl or Cι-C2o-alkylcarbonyl- oxy group, for example methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, non>l, decyl, undecyl, dodecyl, methoxy, ethoxy, »-propoxy, isopropoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecvlow, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, pentyloxycarbo 1, hexyloxycarbonyl, octyloxycarbonyl, nonyloxycarbonyl, decyloxycarbonyl, carbonyl, dodecyloxycarbonyl, acetyl, propionyl, butyryl, valeryl, hexanoy
Figure imgf000008_0001
octanoyl, nonanoyl, decanoyl, undecanoyl, dodecanoyl, terdecanoyl, acetow, propionyloxy, butyryloxy, valeryloxy, hexanoyloxy, heptanoyloxy, octanoylox\, nonanoyloxy, decanoyloxy, undecanoyloxy, dodecanoyloxy, terdecanoyloxy and the like
In a second preferred embodiment of the present invention each or either of the groups B1 and/or B2 comprises a group of formula (IV)
(X2)t2-(Sp2)k2 -(X3)t3 (IV) wherein
Sp2 represents a Ci-2o alkylene group,
X2 and X3 each independently represent -O-, -S-, -NH-, N(CH3)-, -CH(OH)-, -CO-. -CH2(CO)-, -SO-, -CH2(SO)-, -SO2-, -CH2(SO2)-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -SOO-, -OSO-, -SOS-, -CH9-CH2-, -OCH2-.
-CH2O-, -CH=CH-, -C≡C- or a single bond, k2 is an integer, having a value of 0 or 1; and
t2 and t3 are integers, each independently having a value of 0 or 1;
with the proviso that oxygen atoms are not linked one to another.
Preferably B1 and B2 each independently represent a group of formula (IV), wherein:
X2 to X3 each independently represent -0-, -CO-, -COO-, -OCO-, -C≡C-, or a single bond, especially -O-, -COO-, -OCO- or a single bond; and
Sp2 represents a Ci-2o straight-chain alkylene group, especially ethylene. propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene. decylene, undecylene or dodecylene.
Especially preferred compounds are those in which B1 and B2 each independently represent a group of formula (IV) and A1 to A4 and E1 to E2 each independently represent a group of formula (III).
The invention is particularly useful when the groups of MG1 and MG2 have a mesogenic architecture so that compounds of formula (I) are able to be compatible with a host liquid-crystalline single compound or mixture. Thus preferably at least one of MG1 and MG2 represents a mesogenic group comprising at least two optionally-substituted aromatic or non-aromatic carbocyclic or heterocyclic ring systems.
Preferably one or more of MG*and MG2 represents a mesogenic group comprising 1 to 4 aromatic or non-aromatic carbocyclic or heterocyclic ring systems and optionally up to 3 bridging groups. These are more preferably selected from the meanings of formulae (V): Cl-(Zl-C )ai-(Z2-C )a2-(Z3-C4)a3 (V)
in which
C1 to C4 are in each case independently optionally-substituted non-aromatic, aromatic, carbocyclic or heterocyclic groups,
Z1 to Z3 are independently from each other -COO-, -OCO-, -CH2-CH2-, -OCH -, -CH2O-, -CH=€H-, -C≡C-, -CH=CH-COO-, -OCO-CH=CH- or a single bond, and
al, a2 and a3 are independently integers 0 to 3, such that al + a2 + a3 < 3
Especially preferred are those in which C1 to C4 are selected from
Figure imgf000010_0001
with
L being -CH3, -COCH3, -NO2, -CN, or halogen ul being 0, 1, 2, 3, or 4, u2 being 0, 1, 2, or 3, and u3 being 0, 1, or 2 More especially preferred are those in which C1 to C4 are selected from optionally-substituted cyclohexyl or cyclohexylene, phenyl or phenylene, naphthyl or naphthylene or phenanthryl or phenanthrylene
For ease of synthesis, the molecules of formula (I) may possess some symmetrical aspects These include the following possibilities
nl = n2 = 1 ,
A1 to A4 are identical,
E1 and E2 are identical,
MG1 and MG2 are identical,
CG is a chiral group having at least two chiral centres more preferably two adjacent chiral centres, or
B1 and B2 are identical and both consisting of single bonds, oxygen atoms or an optionally-substituted hydrocarbon group of 1 to 3-C atoms
Other aspects of the present invention are
a) a liquid crystalline material, especially in the form of a liquid crystalline mixture, (co)polymer, elastomer, polymer gel or polymer network, comprising at least two components, at least one of which is a chiral compound, characterised in that the chiral compound is a sandwich derivative of formula (I),
b) a liquid crystalline material, especially in the form of a cholesteric mixture, or cholesteric polymer network, comprising at least two components, at least one of which is a chiral compound, characterised in that the chiral compound is a sandwich derivative of formula (I), c) a cholesteric polymer network obtainable by copolymerisation of an optically active polymerisable mesogenic mixture comprising
i) at least one chiral or/and achiral nematic polymerisable mixture chosen from the already reported broad range of chiral and achiral nematic materials, for example as in Adv. Mater 5, 107 (1993), Mol. Oγst. Liq. Cryst 307, 111 (1997), J. Mat. Chem 5, 2047 (1995) or in patent publications US 5593617, US 5567349, GB-A-2297556, GB-A-2299333, DE-A-19504224, EP-A-0606940, EP-A-0643121 and EP-A-0606939, optionally selected from EP-A-0606940, EP-A-0643121 and EP-A-0606939,
ii) at least one chiral dopant of formula (I),
iii) an initiator,
iv) optionally a non-mesogenic compound having at least one polymerisable functional group, more optionally a diacrylate compound, and
v) optionally a stabiliser,
d) chiral polymerisable cholesteric mixtures, essentially consisting of
i) 70 to 99 %, preferably 85 to 95 % by weight of at least one achiral polymerisable liquid crystal,
ii) 0.1 to 30 %, preferably 1 to 15 % by weight of a chiral compound of formula I,
iii) 0 1 to 5 %, preferably 0 2 to 2 % by weight of a photoinitiator, and
iv) 0 to 5 %, preferably 0 1 to 1 % of a stabiliser, and e) a cholesteric film obtainable by the steps comprising ordering the above mixture in the monomeric state and in situ UV polymerisation of the resulting ordered mixture.
The invention also includes
a) the use of the compounds as dopants for liquid crystals,
b) the use of the compounds or liquid crystalline materials for manufacturing a polymeric cholesteric layer; and
c) the use of the cholesteric polymer network, chiral polymerisable cholesteric mixtures, or cholesteric film, in optical components such as optical filters and polarisers, and especially colour filters, optical pass band filters, solid state cholesteric filters for projection displays and circular polarisers
The compounds of the invention may be readily prepared using methods that are well known to the person skilled in the art, such as those documented in Houben-Weyl, Methoden der Organischen Chemie, Thieme-Verlag, Stuttgart The compounds may for example be made according to the following reaction schemes
Scheme 1:
Figure imgf000014_0001
Scheme 2:
Figure imgf000015_0001
Crθ3/H:SθyH:0 Acetone
Figure imgf000015_0002
Scheme 3:
Figure imgf000016_0001
P(C6H5)3 PdCl2 Cul Et3N
Figure imgf000016_0002
Cr03/H2S04/H20 Acetone
Figure imgf000016_0003
EDC N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride, DMAP:
N,N-Dimethylaminopyridine; DMF: N,N-Dimethylformamide
According to the synthetic ways drawn in Schemes 1-3 typical examples representing polymerisable chiral "sandwich" derivatives shown in the following list of compounds are prepared. This list is, however, to be understood only as illustrative without limiting the scope of the present invention:
Figure imgf000017_0001
E. 1
Figure imgf000018_0001
E.2
Figure imgf000018_0002
E.3
Figure imgf000018_0003
Figure imgf000019_0001
E. 5
Figure imgf000019_0002
E. 6
Figure imgf000020_0001
E. 7
Figure imgf000020_0002
E. 8
Figure imgf000020_0003
E. 9 Example 1:
Diisopropyl L-2,3-bis-{2,5-bis-[4-(6-acryloyloxyhexyloxy)benzoyIoxy]benzoyloxy}- succinate
Figure imgf000021_0001
a) 2, 5-Di-[4-(6-acryloyloxyhexyloxy) benzoyloxyfhenzaldehyde
Figure imgf000021_0002
A solution of mesyl chloride (4.23 g, 36.94 mmol) in 10 ml of dry THF was added dropwise under argon over a period of 15 minutes to a cooled (-25 °C) solution of
4-(6-acryloyloxyhexyloxy)benzoic acid and triethylamine (20 ml) in 80 ml of dry THF.
The reaction mixture was then stirred for 60 min at -25 °C, treated with a solution of
2,5-dihydroxybenzaldehyde (2.3 g , 16.65 mmol) in 60 ml of dry THF containing 195 mg of DMAP and further stirred at -25°C for 2h. The reaction mixture was then allowed to warm to room temperature and stirring was continued overnight. The reaction mixture was then poured into 120 ml of saturated NaHCO3 and extracted with
2 x 200 ml of ether. The combined organic extracts were washed with 3N HCI (200 ml) and semi-saturated NaCl solution (2 x 100 ml), dried over MgSO4, filtered and dried to give a slightly yellow pasty material. This was purified by flash chromatography over a short silica column (CH2Cl2/Et2O : 19.5 / 0.5) to give a white residue (9.25 g) which was dissolved in CH C12 (25 ml) then recrystallised from ethanol (250 ml) to give pure 2,5-di-[4-(6-acryloyloxy-hexyloxy)benzoyloxy]benzaldehyde as a white crystalline material. Yield 8.5 g.
b) 2, 5-Di-[4-(6-acιγloyloxyhexyloxy benzoyloxy]benzoιc acid
Figure imgf000022_0001
Jones oxidant (CrO3/H Sθ42O) (48 ml) was added to a ice-cooled solution of 2,5-di-
[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzaldehyde (8.24 g, 12 mmol) in acetone (300 ml) in a dropwise fashion over a period of 30 min The reaction mixture was stirred overnight at room temperature The resulting green-orange mixture was filtered off to leave a green precipitate that was washed with 600 ml of ether The combined organic solutions were washed with water until the orange coloration disappeared (6 x 250 ml) The colourless organic solution obtained was washed with saturated NaCl solution (2 x 300 ml), dried over MgSO4 and filtered Removal of the solvent gave pure 2,5-di-[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoic acid as a white crystalline material Yield 8.5 g
c) Diisopropyl L-2, 3 -bis- {2, 5-bιs-[4-(6-acryloyloxyhexylox) )benzoyloxy]benzoyl- oxyjsiiccmate
A solution of mesyl chloride (1 10 ml) in 5 ml of dry THF is dropwise added to a solution of 2',5'-bis-[2,5-di-(4-(6-acryloyloxyhexyloxy)benzoyloxy)]benzoic acid (10 g) and triethylamine (19 8 ml) in 125 ml of dry THF, cooled at -25°C and maintained and under argon atmosphere After complete addition (15 min), the reaction mixture is further stirred for 120 min at -25 °C then treated with a solution of diisopropyl L-tartrate (1 35 g) in 20 ml of dry THF containing 695 mg of DMAP and the reaction mixture is further stirred at -25 °C for 2 h. The temperature is then allowed to reach room temperature and stirring is continued overnight The reaction mixture is filtered over Celite and evaporated to dryness to afford a slightly beige pasty material This is then flash chromatographed over a silica column affording pure diisopropyl L-2,3-bis-{2,5- bis-[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoyloxy}succinate [the "L" indicating the formal derivation of the compound from diisopropyl L-tartrate] as a transparent oily material which becomes pasty upon standing Yield 5 0 g
Example 2:
Diisopropyl D-2, 3-bιs-[2, 5-bιs-[4-(6-acryloyloxyhexyloxy) benzoyloxy ] benzoyloxy- sitccmate
Figure imgf000023_0001
Following the procedure described in Example 1 (C), the reaction was performed with 10 g of 2',5'-bis-[2,5-di-(4-(6-acryloyloxyhexyloxy)benzoyloxy)]benzoic acid, 1 10 ml of mesyl chloride , 19 8 ml of triethylamine, 1 5 g of diisopropyl L-tartrate and 695 mg of DMAP to afford, after flash chromatography over a silica column, pure diisopropyl D-2,3-bis-{2,5-bis-[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoyloxysuccinate [the '"D" indicating the formal derivation of the compound from diisopropyl D-tartrate] as a transparent oily material which becomes pasty upon standing Yield 6 3 g Example 3:
O, O-D - {2, 5-bιs-[4-(6-acryloyloxyhexyloxy) benzoyloxy ]benzoyl}-l, 4, 3, 6-dιanhydro-D- mamntol
Figure imgf000024_0001
Following the procedure described in Example 1 (C), the reaction was performed with 1 5 g of 2',5'-bis-[2,5-di-(4-(6-acryloyloxyhexyloxy)benzoyloxy)]benzoic acid, 0 17 ml of mesyl chloride , 3 ml of triethylamine, 0 14 g of 1,4,3,6-dianhydro-D-mannitol and 61 mg of DMAP in 50 ml of THF to afford, after flash chromatography over a silica column, pure O,O-di- { 2,5-bis-[4-(6-acryloyloxyhexyloxy)benzoylox> jbenzoyl } - -1,4,3,6-dianhydro-D-mannitol as white crystalline material Yield 0 28 g
Example 4:
A mixture is formulated consisting of
1 % by weight of
Figure imgf000025_0001
and
99 % by weight of
Figure imgf000025_0002
This mixture forms a cholesteric phase with a pitch of p = 4 μm.

Claims

Claims
1. A compound of formula I
Figure imgf000026_0001
in which
A1 to A4 each independently represent hydrogen, an optionally-substituted methyl group, or an optionally-substituted hydrocarbon group of 2 to 80 C-atoms, in which one or more C-atoms may be replaced by a heteroatom, in such a way that oxygen atoms are not linked to one another,
E and E2 each independently represent hydrogen, an optionally-substituted methyl group, or an optionally-substituted hydrocarbon group of 2 to
80 C-atoms, in which one or more C-atoms may be replaced by a heteroatom, in such a way that oxygen atoms are not linked to one another,
B nd B2 each independently represent a single bond, an oxygen atom or an optionally-substituted hydrocarbon group of 1 to 80 C-atoms, in which one or more C-atoms may be replaced by a heteroatom, in such a way that oxygen atoms are not linked to one another, G1 and MG2 each independently represent an optionally-substituted aromatic or non-aromatic carbocyclic or heterocyclic ring system, with 1 to 80 C-atoms;
CG is a divalent or polyvalent chiral group; and
nl and n2 are each independently 1 or 2, where "nl = 2" (or "n2 = 2") indicates the presence of two separate linkages via the groups B1 (or the groups B2) between the groups MG1 and CG (or CG and MG2);
and in which further the substructures A'-MG'-A2 and A3-MG2-A4 each have a longitudinal axis and are linked lateral to the said longitudinal axis to B1 and B2, respectively.
2. A compound as claimed in claim 1, in which CG is a chiral group derived from a sugar, from an optically active biaryl group, or from a bifunctional or polyfunctional compound comprising an optically active alcohol, glycol or amino acid.
3. A compound as claimed in claim 1 or 2 in which:
nl = n2 = 1
4. A compound as claimed in any preceding claim, in which at least one of A1 to A4 , E1 and E2 includes a polymerisable group.
5. A compound as claimed in claim 4, in which at least one of A1 to A4 , E1 and E2 independently is selected from formula (II):
P-(Spl)kι-(χl)tι - (II) wherein: P is hydrogen or a polymerisable group selected from groups comprising CH2=CW-, CH2=CW-O-, CH2=CW-COO-, CH2=C(Ph)-COO-,
CH2=CH-COO-Ph-, CH2=CW-CO-NH-, CH2=C(Ph)-CONH-,
CH2=C(COOR')-CH2-COO-, CH2=CH-O-, CH2=CH-OOC-, (Ph)-CH=CH-, CH3-C=N-(CH2)m3-, HO-, HS-, HO-(CH2)m3-, HS-(CH2)m3-, HO(CH2)m3COO-,
HS(CH2)m3COO-, HWN-, HOC(O)-, CH2=CH-Ph-(O)m4.
Figure imgf000028_0001
wherein
W represents H, F, CI, Br or I or a Ciό alkyl group, m3 is an integer having a value of from 1 to 9, m4 is an integer having a value of 0 or 1, R' represents a C1-5 alkyl group, and R" represents a C1-5 alkyl group, methoxy, cyano, F, CI, Br or I,
Sp1 represents an optionally-substituted Ci- o alkylene group, in which one or more C-atoms may be replaced by a heteroatom,
k1 is an integer having a value of from 0 to 4,
X1 represents -O-, -S-, -NH-, N(CH3)-, -CH(OH)-, -CO-, -CH2(CO)-, -SO-, -CH2(SO)-, -S02-, -CH2(SO2)-, -COO-, -OCO-, -OCO-O-, -S-CO-. -CO-S-, -SOO-, -OSO-, -SOS-, -CH2-CH2-, -OCH2-, -CH2O-, -CH=CH-, or -C≡C-, and
t1 is an integer having a value of 0 or 1 ,
wherein the term Ph denotes phen\ lene and (Ph) denotes phenyl
6 A compound as claimed in claim 5, in which one or more of CH groups present in the hydrocarbon chain of an the optionally-substituted Cι_2o alkylene group Sp1 is replaced, independently, by one or more groups selected from -O-, -S-, -NH-, N(CH3)-, -CH(OH)-, -CO-, -CH2(CO)-, -SO-, -CH2(SO)-, -SO2-, -CH2(SO2)-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -SOO-, -OSO-, -SOS-, -C≡C-, -(CF2)-r , -(CD2)S- or C(W1)=C(W2)-, with the proviso that no two oxygen atoms are directly linked to each other, wherein W1 and W2 each represent, independently, H, H-(CH )qi- or CI and the integers r, s and ql each independently represent a number of between 1 and 15
7 A compound as claimed in any preceding claim, in which A1 to A4 and E1 to E2 each independently represent a group of formula (III)
P2-Sp5-X4- (III) wherein
P2 represents hydrogen, CH2=CW5- or CH2=CW5-(C0 20-
Figure imgf000029_0001
wherein
W5 represents H, CH3, F, CI, Br or I, and v2 is O or l,
R' represents a C1-5 alkyl group, and R" represents a C i-5 alkyl group, methoxy, cyano, F, CI, Br or I,
Sp5 represents a C1.20 straight-chain alkylene group, especially ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, or dodecylene, and
X4 represents -O-, -CO-, -COO-, -OCO-, -C≡C-, or a single bond, especially -O-, -COO-, -OCO- or single bond
8. A compound as claimed in any preceding claim, in which each or either of the groups B1 and/or B2 comprises a group of formula (IV):
(X )t2-(Sp )k2 -(X3)t3 (IV) wherein:
Sp2 represents a Ci-2o alkylene group;
X2 and X3 each independently represent -O-, -S-, -NH-, N(CH3)-, -CH(OH)-, -CO-, -CH2(CO)-, -SO-, -CH2(SO)-, -SO2-, -CH (SO2)-, -COO-, -OCO-,
-OCO-O-, -S-CO-, -CO-S-, -SOO-, -OSO-, -SOS-, -CH2-CH2-. -OCH2-, -CH2O-, -CH=CH-, -C≡C- or a single bond;
k2 is an integer, having a value of 0 or 1 ; and
t2 and t3 are integers, each independently having a value of 0 or 1;
with the proviso that oxygen atoms are not linked one to another.
9. A compound as claimed in claim 8, in which B1 and B2 each independently represent a group of formula (IV), wherein:
X2 to X3 each independently represent -O-, -CO-, -COO-, -OCO-. -C≡C-, or a single bond, especially -O-, -COO-, -OCO- or a single bond; and
Sp2 represents a Ci- straight-chain alkylene group, especially ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene or dodecylene. 10 A compound as claimed in any preceding claim, in which at least one of MG1 and MG2 represents a mesogenic group comprising at least two optionally-substituted aromatic or non-aromatic carbocyclic or heterocyclic ring systems
11 A compound as claimed in any preceding claim, in which one or more of MG1 and MG2 represents a mesogenic group comprising 1 to 4 aromatic or non-aromatic carbocyclic or heterocyclic ring systems and optionally up to 3 bridging groups
12 A compound as claimed in claim 11, in which MG1 and MG2 are selected from the meanings of formulae (V)
Cl-(Zl-C2)ai-(Z2-C )a2-(Z3-C4)a3 (V)
in which
C o C are in each case independently optionally-substituted non-aromatic, aromatic, carbocyclic or heterocyclic groups,
Z1 to Z3 are independently from each other -COO-, -OCO-. -CH2-CH2-, -OCH -, -CH2O-, -CH=CH-, -C≡C-, -CH=CH-COO-, -OCO-CH=CH- or a single bond, and
al, a2 and a3 are independently integers 0 to 3, such that al - a2 + a3 < 3
13 A compound as claimed in claim 12, in which C1 to C4 are selected from
Figure imgf000032_0001
with
L being -CH3, -COCH3, -NO2, -CN, or halogen ul being 0, 1, 2, 3, or 4, u2 being 0, 1, 2, or 3, and u3 being 0, 1, or 2
14 A compound as claimed in claim 13, in which C1 to C4 are selected from optionally-substituted cyclohexyl or cyclohexylene, phenyl or phenylene, naphth\ l or naphthylene or phenanthryl or phenanthrylene
15 A compound as claimed in any preceding claim, in which A1 to A4 are identical
16 A compound as claimed in any preceding claim, in which E1 and E2 are identical
17 A compound as claimed in any preceding claim, in which MG1 and MG2 are identical
18 A compound as claimed in any preceding claim, in which CG is a chiral group having at least two chiral centres more preferably two adjacent chiral centres 19 A compound as claimed in any preceding claim, in which B1 and B2 are identical and both consisting of single bonds, oxygen atoms or an optionally-substituted hydrocarbon group of 1 to 3-C atoms
20 A liquid crystalline material, in the form of a liquid crystalline mixture, (co)polymer, elastomer, polymer gel or polymer network, comprising at least two components, at least one of which is a chiral compound, characterised in that the chiral compound is a compound of formula (I) as claimed in claim 1
21 A liquid crystalline material, in the form of a cholesteric mixture, or cholesteric polymer network, comprising at least two components, at least one of which is a chiral compound, characterised in that the chiral compound is a compound of formula (I) as claimed in claim 1
22 A cholesteric polymer network obtainable by copolymerisation of an opticalh active polymerisable mesogenic mixture comprising
i) at least one chiral or/and achiral nematic polymerisable mixture chosen from chiral and achiral nematic materials,
ii) at least one chiral dopant of formula (I) as claimed in claim 1 ,
iii) an initiator,
iv) optionally a non-mesogenic compound having at least one polymerisable functional group, more optionally a diacrylate compound, and
v) optionally a stabiliser, 3 A chiral polymerisable cholesteric mixture, essentially consisting of
i) 70 to 99 % by weight of at least one achiral polymerisable liquid crystal,
ii) 0 1 to 30 % by weight of a chiral compound of formula I as claimed in claim
1,
iii) 0 1 to 5 % by weight of a photoinitiator, and
iv) 0 to 5 % of a stabiliser
24 A cholesteric film obtainable by the steps comprising ordering a chiral polymerisable cholesteric mixture as claimed in claim 23 in the monomeric state and m situ UV polymerisation of the resulting ordered mixture
25 Use of a compound as claimed in any one of claims 1 to 19 as a dopant for liquid crystals
26 Use of a compound as claimed in any one of claims 1 to 19, or a liquid crystalline material as claimed in claim 20 or 21, for manufacturing a polymeric cholesteric layer
27 Use of a cholesteric polymer network as claimed in claim 22, a chiral polymerisable cholesteric mixture as claimed in claim 23, or a cholesteric film as claimed in claim 24, in optical components such as colour filters, optical pass band filters and polarisers
PCT/CH2000/000673 1999-12-23 2000-12-20 Optically active materials WO2001047862A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/168,137 US6905739B2 (en) 1999-12-23 2000-12-20 Optically active materials
JP2001549336A JP2003519113A (en) 1999-12-23 2000-12-20 Optically active substance
EP00982805A EP1252131A1 (en) 1999-12-23 2000-12-20 Optically active materials
AU19795/01A AU1979501A (en) 1999-12-23 2000-12-20 Optically active materials
KR1020027008072A KR20020062767A (en) 1999-12-23 2000-12-20 Optically active materials
HK02109386.1A HK1047740A1 (en) 1999-12-23 2002-12-28 Optically active materials

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99310561 1999-12-23
EP99310561.8 1999-12-23
GB9930557.5 1999-12-23
GBGB9930557.5A GB9930557D0 (en) 1999-12-23 1999-12-23 Optically active materials

Publications (1)

Publication Number Publication Date
WO2001047862A1 true WO2001047862A1 (en) 2001-07-05

Family

ID=26153628

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2000/000673 WO2001047862A1 (en) 1999-12-23 2000-12-20 Optically active materials

Country Status (10)

Country Link
US (1) US6905739B2 (en)
EP (1) EP1252131A1 (en)
JP (1) JP2003519113A (en)
KR (1) KR20020062767A (en)
CN (1) CN1407966A (en)
AU (1) AU1979501A (en)
GB (1) GB9930557D0 (en)
HK (1) HK1047740A1 (en)
TW (1) TW587076B (en)
WO (1) WO2001047862A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1432673A1 (en) * 2001-09-24 2004-06-30 Rolic AG Liquid crystalline "laterally polymerizable" compounds
WO2005054406A1 (en) * 2003-12-04 2005-06-16 Rolic Ag Additive components for liquid crystalline materials
US9873678B2 (en) 2014-03-18 2018-01-23 Astrazeneca Ab Chemical compounds
US10611760B2 (en) 2014-09-03 2020-04-07 C4X Discovery Limited Therapeutic compounds as inhibitors of the orexin-1 receptor
US10696654B2 (en) 2016-01-29 2020-06-30 C4X Discovery Limited Therapeutic compounds
US11697666B2 (en) 2021-04-16 2023-07-11 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
US11767337B2 (en) 2020-02-18 2023-09-26 Gilead Sciences, Inc. Antiviral compounds

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339812B1 (en) * 2000-11-20 2008-07-16 MERCK PATENT GmbH Chiral photoisomerizable compounds
US7311948B2 (en) * 2001-09-24 2007-12-25 Koninklijke Philips Electronics N.V. Isosorbide derivatives
JP4940754B2 (en) * 2005-05-19 2012-05-30 Jnc株式会社 Polymerizable liquid crystal compound, liquid crystal composition and polymer
DE102009026820A1 (en) * 2008-09-08 2010-03-11 Evonik Röhm Gmbh Functionalized (meth) acrylate monomer, polymer, coating agent and method of preparation and crosslinking
BR112017026839A2 (en) 2015-06-15 2018-08-14 3M Innovative Properties Co optical cell, emissive screen and film reel
US9599761B1 (en) 2015-09-03 2017-03-21 3M Innovative Properties Company Thermoformed multilayer reflective polarizer
JP7101182B2 (en) 2016-11-15 2022-07-14 スリーエム イノベイティブ プロパティズ カンパニー Optical lenses and eyewear including optical lenses
WO2018116080A1 (en) 2016-12-20 2018-06-28 3M Innovative Properties Company Optical system
US11156757B2 (en) 2017-03-06 2021-10-26 3M Innovative Properties Company High contrast optical film and devices including the same
EP3593180A1 (en) 2017-03-06 2020-01-15 3M Innovative Properties Company High contrast optical film and devices including the same
US20200031786A1 (en) * 2017-03-17 2020-01-30 Zeon Corporation Polymerizable compound, polymerizable liquid crystal mixture, polymer, optical film, optically anisotropic body, polarizing plate, display device, antireflection film, and compound
CN110506228B (en) 2017-03-31 2021-12-14 3M创新有限公司 Optical system
JP2020537194A (en) 2017-10-09 2020-12-17 スリーエム イノベイティブ プロパティズ カンパニー Optical components and optical systems
CN111316146B (en) 2017-10-10 2022-06-03 3M创新有限公司 Curved reflective polarizing film and method of forming the same
JP2021500629A (en) 2017-10-25 2021-01-07 スリーエム イノベイティブ プロパティズ カンパニー Optical retarder segment
US11846773B2 (en) 2017-10-27 2023-12-19 3M Innovative Properties Company Optical system
JP7257394B2 (en) 2017-10-27 2023-04-13 スリーエム イノベイティブ プロパティズ カンパニー Patterned optical retarder and manufacturing method thereof
JP7466516B2 (en) 2018-07-13 2024-04-12 スリーエム イノベイティブ プロパティズ カンパニー Optical system and optical film
WO2020035791A1 (en) 2018-08-14 2020-02-20 3M Innovative Properties Company Optical system
JP7265621B2 (en) * 2019-05-10 2023-04-26 富士フイルム株式会社 sensor
US20220357493A1 (en) 2019-09-27 2022-11-10 3M Innovative Properties Company Color neutral emissive display with notched reflective polarizer
JP2023508416A (en) 2019-12-26 2023-03-02 スリーエム イノベイティブ プロパティズ カンパニー Thin film laminate for circular polarizer

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0675186A1 (en) * 1994-03-30 1995-10-04 F. Hoffmann-La Roche AG Photo-curable liquid crystals
EP0699731A2 (en) * 1994-08-31 1996-03-06 F. Hoffmann-La Roche Ag Optically avtive smectic photo-curable liquid crystals
EP0755915A2 (en) * 1995-07-28 1997-01-29 Rolic AG Photocrosslinkable chiral doping agents
EP0837054A2 (en) * 1996-10-18 1998-04-22 Daimler-Benz Aktiengesellschaft Compounds and their use as well as a process for the preparation of polymeric liquid crystals therefrom
WO1999064383A1 (en) * 1998-06-12 1999-12-16 Rolic Ag Optically active compounds
WO2000007975A1 (en) * 1998-08-07 2000-02-17 Rolic Ag Liquid crystalline compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707544A (en) * 1995-06-07 1998-01-13 Rolic Ag Chromophore-containing photo cross-linkable liquid crystals
DE59605841D1 (en) * 1995-07-28 2000-10-12 Rolic Ag Zug Photocrosslinkable chiral dopants
DE19781752T1 (en) * 1996-07-01 1999-09-02 Merck Patent Gmbh Chiral dopants
DE19843724A1 (en) * 1997-10-08 1999-04-15 Basf Ag Chiral compound used as polymerizable, high-twisting-power dopant for the production of cholesteric networks
DE19824972A1 (en) * 1998-06-04 1999-12-09 Basf Ag Use of cholesteric liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations
GB9815269D0 (en) * 1998-07-14 1998-09-09 Rolic Ag Compositions
DE19855757A1 (en) * 1998-12-03 2000-06-21 Merck Patent Gmbh Cross-bridged cyclohexane derivatives and liquid-crystalline medium
US6773766B2 (en) * 1998-12-22 2004-08-10 Basf Aktiengesellschaft Utilization of polymerizable liquid crystal substances for the production of optical components
GB9906168D0 (en) * 1999-03-17 1999-05-12 Rolic Ag Liquid crystal compounds
GB9908934D0 (en) * 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
DE10016524A1 (en) * 2000-04-03 2001-10-04 Basf Ag Polymerizable liquid crystals
TW555837B (en) * 2001-07-02 2003-10-01 Merck Patent Gmbh Chiral compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0675186A1 (en) * 1994-03-30 1995-10-04 F. Hoffmann-La Roche AG Photo-curable liquid crystals
EP0699731A2 (en) * 1994-08-31 1996-03-06 F. Hoffmann-La Roche Ag Optically avtive smectic photo-curable liquid crystals
EP0755915A2 (en) * 1995-07-28 1997-01-29 Rolic AG Photocrosslinkable chiral doping agents
EP0837054A2 (en) * 1996-10-18 1998-04-22 Daimler-Benz Aktiengesellschaft Compounds and their use as well as a process for the preparation of polymeric liquid crystals therefrom
WO1999064383A1 (en) * 1998-06-12 1999-12-16 Rolic Ag Optically active compounds
WO2000007975A1 (en) * 1998-08-07 2000-02-17 Rolic Ag Liquid crystalline compounds

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1432673A1 (en) * 2001-09-24 2004-06-30 Rolic AG Liquid crystalline "laterally polymerizable" compounds
WO2005054406A1 (en) * 2003-12-04 2005-06-16 Rolic Ag Additive components for liquid crystalline materials
US8105662B2 (en) 2003-12-04 2012-01-31 Rolic Ag Additive components for liquid crystalline materials
US9873678B2 (en) 2014-03-18 2018-01-23 Astrazeneca Ab Chemical compounds
US10336725B2 (en) 2014-03-18 2019-07-02 Astrazeneca Ab Chemical compounds
US10954211B2 (en) 2014-03-18 2021-03-23 Astrazeneca Ab Chemical compounds
US10611760B2 (en) 2014-09-03 2020-04-07 C4X Discovery Limited Therapeutic compounds as inhibitors of the orexin-1 receptor
US10696654B2 (en) 2016-01-29 2020-06-30 C4X Discovery Limited Therapeutic compounds
US11130746B2 (en) 2016-01-29 2021-09-28 C4X Discovery Limited Therapeutic compounds
US11753398B2 (en) 2016-01-29 2023-09-12 C4X Discovery Limited Therapeutic compounds
US11767337B2 (en) 2020-02-18 2023-09-26 Gilead Sciences, Inc. Antiviral compounds
US11697666B2 (en) 2021-04-16 2023-07-11 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides

Also Published As

Publication number Publication date
EP1252131A1 (en) 2002-10-30
JP2003519113A (en) 2003-06-17
TW587076B (en) 2004-05-11
GB9930557D0 (en) 2000-02-16
HK1047740A1 (en) 2003-03-07
KR20020062767A (en) 2002-07-29
US20030028048A1 (en) 2003-02-06
CN1407966A (en) 2003-04-02
AU1979501A (en) 2001-07-09
US6905739B2 (en) 2005-06-14

Similar Documents

Publication Publication Date Title
WO2001047862A1 (en) Optically active materials
KR100726265B1 (en) A liquid crystal compound, and a liquid crystalline material and an optical or electro-optical device comprising the same
KR100426296B1 (en) New Polymeric Liquid Crystal Compound
EP1100766B1 (en) Crosslinkable liquid crystalline compounds
US6733690B1 (en) Laterally substituted curable liquid crystals
EP1100855B1 (en) Compositions
JP4577990B2 (en) Liquid crystal compound
US6607677B1 (en) Optically active compounds
EP1046631A1 (en) Liquid crystalline compounds
EP1093454B1 (en) Chiral compounds and their use as doping agents in liquid crystals

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2002/00557/MU

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 008166994

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2000982805

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10168137

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2001 549336

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020027008072

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020027008072

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2000982805

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000982805

Country of ref document: EP